Clinical trial
Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension
NCT00235001 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00235001 |
|---|---|
| Title | Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension |
| Official title | A Multicenter, Open, Phase IV, 24-Hour Ambulatory Blood Pressure Monitoring Study of the Efficacy and Safety of Tarka in Patients With Arterial Hypertension |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | trandolapril/verapamil |
| Enrollment | 120 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2006 |
| First posted | Oct 10, 2005 |
| Last update posted | Jul 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: